AZM

5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE


View summary at Ligand Expo



Chemical Component Summary

Name5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE
IdentifiersN-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide
FormulaC4 H6 N4 O3 S2
Molecular Weight222.25
TypeNON-POLYMER
Isomeric SMILESCC(=O)Nc1sc(nn1)[S](N)(=O)=O
InChIInChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)
InChIKeyBZKPWHYZMXOIDC-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count19
Chiral Atom Count0
Bond Count19
Aromatic Bond Count5

Drug Info: DrugBank

DrugBank IDDB00819 
NameAcetazolamide
Groups
  • approved
  • vet_approved
DescriptionOne of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Synonyms
  • 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
  • 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide
  • Acetazolamide
  • Acetazolamid
  • 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide
Brand Names
  • AcetaZOLAMIDE
  • Diamox Src 500mg
  • Acetazolamide
  • Diamox IV 500mg
  • Acetazolamide for Injection, USP
IndicationFor adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
Categories
  • Anticonvulsants
  • Antiglaucoma Agents
  • Antiglaucoma Preparations and Miotics
  • Carbonic Anhydrase Inhibitors
  • Cardiovascular Agents
ATC-Code
  • G01AE10
  • S01EC01
CAS number59-66-5

Drug Targets

NameTarget SequencePharmacological ActionActions
Carbonic anhydrase 1MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISV...unknowninhibitor
Carbonic anhydrase 2MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS...unknowninhibitor
Carbonic anhydrase 4MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDR...unknowninhibitor
Carbonic anhydrase 12MPRRSLHAAAVLLLVILKEQPSSPAPVNGSKWTYFGPDGENSWSKKYPSC...unknowninhibitor
Carbonic anhydrase 14MLFSALLLEVIWILAADGGQHWTYEGPHGQDHWPASYPECGNNAQSPIDI...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682